Terms: = Germ cell tumor AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Treatment
292 results:
1. Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma.
Versluis JM; Blankenstein SA; Dimitriadis P; Wilmott JS; Elens R; Blokx WAM; van Houdt W; Menzies AM; Schrage YM; Wouters MWJM; Sanders J; Broeks A; Scolyer RA; Suijkerbuijk KPM; Long GV; Akkooi ACJV; Blank CU
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38677880
[TBL] [Abstract] [Full Text] [Related]
2. Analyses of tertiary lymphoid structures observed in cases of Merkel cell carcinoma showing spontaneous regression.
Nakamura M; Yoshimitsu M; Magara T; Kano S; Kato H; Morita A
Exp Dermatol; 2024 Mar; 33(3):e15062. PubMed ID: 38532566
[TBL] [Abstract] [Full Text] [Related]
3. Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma.
Su DG; Schoenfeld DA; Ibrahim W; Cabrejo R; Djureinovic D; Baumann R; Rimm DL; Khan SA; Halaban R; Kluger HM; Olino K; Galan A; Clune J
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38519058
[TBL] [Abstract] [Full Text] [Related]
4. The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma.
Feichtenschlager V; Chen L; Zheng YJ; Ho W; Sanlorenzo M; Vujic I; Fewings E; Lee A; Chen C; Callanan C; Lin K; Qu T; Hohlova D; Vujic M; Hwang Y; Lai K; Chen S; Nguyen T; Muñoz DP; Kohwi Y; Posch C; Daud A; Rappersberger K; Kohwi-Shigematsu T; Coppé JP; Ortiz-Urda S
Mol Cancer; 2024 Feb; 23(1):40. PubMed ID: 38383439
[TBL] [Abstract] [Full Text] [Related]
5. Duodenal malignant melanoma: Primary and metastatic case series and literature review.
Zhou B; Li X; Liu J; Peng L; Liu X
Medicine (Baltimore); 2024 Feb; 103(6):e37138. PubMed ID: 38335433
[TBL] [Abstract] [Full Text] [Related]
6. Targeting cd20-expressing malignant melanoma cells augments BRAF inhibitor killing.
Mukhtar AB; Morgan HJ; Gibbs A; Davies GE; Lovatt C; Patel GK
Br J Dermatol; 2024 Apr; 190(5):729-739. PubMed ID: 38288865
[TBL] [Abstract] [Full Text] [Related]
7. Targeted Therapy and Immunotherapy for Advanced Malignant Conjunctival tumors: Systematic Review.
Serbest Ceylanoglu K; Guneri Beser B; Singalavanija T; Juntipwong S; Worden FP; Demirci H
Ophthalmic Plast Reconstr Surg; 2024 Jan-Feb 01; 40(1):18-29. PubMed ID: 38241616
[TBL] [Abstract] [Full Text] [Related]
8. Apocynin exerts neuroprotective effects in fumonisin b1-induced neurotoxicity via attenuation of oxidative stress and apoptosis in an animal model.
Krishnaswamy K; Manasa V; Khan MT; Serva Peddha M
J Food Sci; 2024 Feb; 89(2):1280-1293. PubMed ID: 38193205
[TBL] [Abstract] [Full Text] [Related]
9. Bioinspired Lipoproteins of Furoxans-Gemcitabine Preferentially Targets Glioblastoma and Overcomes Radiotherapy Resistance.
Sun M; Xie H; Zhang W; Li X; Jiang Z; Liang Y; Zhao G; Huang N; Mao J; Liu G; Zhang Z
Adv Sci (Weinh); 2024 Feb; 11(6):e2306190. PubMed ID: 38049204
[TBL] [Abstract] [Full Text] [Related]
10. Combining CSPG4-CAR and cd20-CCR for treatment of metastatic melanoma.
Teppert K; Winter N; Herbel V; Brandes C; Lennartz S; Engert F; Kaiser A; Schaser T; Lock D
Front Immunol; 2023; 14():1178060. PubMed ID: 37901209
[TBL] [Abstract] [Full Text] [Related]
11. Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy.
Martinez-Morilla S; Moutafi M; Fernandez AI; Jessel S; Divakar P; Wong PF; Garcia-Milian R; Schalper KA; Kluger HM; Rimm DL
Oncoimmunology; 2023; 12(1):2260618. PubMed ID: 37781235
[TBL] [Abstract] [Full Text] [Related]
12. Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma.
Brignole C; Calarco E; Bensa V; Giusto E; Perri P; Ciampi E; Corrias MV; Astigiano S; Cilli M; Loo D; Bonvini E; Pastorino F; Ponzoni M
J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37775116
[TBL] [Abstract] [Full Text] [Related]
13. Liquid Biopsy in Low-Grade Glioma: A Systematic Review and a Proposal for a Clinical Utility Score.
Zanin L; Sachkova A; Panciani PP; Rohde V; Fontanella MM; Schatlo B
Cell Mol Neurobiol; 2023 Nov; 43(8):3833-3845. PubMed ID: 37704931
[TBL] [Abstract] [Full Text] [Related]
14. Modulation of AMPK Significantly Alters Uveal Melanoma tumor cell Viability.
Deliktas O; Gedik ME; Koc I; Gunaydin G; Kiratli H
Ophthalmic Res; 2023; 66(1):1230-1244. PubMed ID: 37647867
[TBL] [Abstract] [Full Text] [Related]
15. Lycorine inhibits the proliferation of neuroblastoma neuro-2a cells by inducing G2/M phase cell cycle arrest and apoptosis.
Jiang X; Lu X; Tang J; Xia Y; Zhao Z; Quan M; Xiang X
Pak J Pharm Sci; 2023 Mar; 36(2):379-385. PubMed ID: 37530144
[TBL] [Abstract] [Full Text] [Related]
16. CCNB1IP1 prevents ubiquitination-mediated destabilization of MYCN and potentiates tumourigenesis of MYCN-amplificated neuroblastoma.
Zhou Y; Yan H; Zhou Q; Wang P; Yang F; Yuan Z; Du Q; Zhai B
Clin Transl Med; 2023 Jul; 13(7):e1328. PubMed ID: 37461251
[TBL] [Abstract] [Full Text] [Related]
17. A multimodal imaging-based classification for pediatric diffuse intrinsic pontine gliomas.
Pan C; Zhang M; Xiao X; Kong L; Wu Y; Zhao X; Sun T; Zhang P; Geng Y; Zuo P; Wang Y; Li X; Gu G; Li T; Wu Z; Zhang J; Zhang L
Neurosurg Rev; 2023 Jun; 46(1):151. PubMed ID: 37358632
[TBL] [Abstract] [Full Text] [Related]
18. Vitamin B complex suppresses neuroinflammation in activated microglia: in vitro and in silico approach combined with dynamical modeling.
Rakić M; Lunić T; Bekić M; Tomić S; Mitić K; Graovac S; Božić B; Božić Nedeljković B
Int Immunopharmacol; 2023 Aug; 121():110525. PubMed ID: 37356121
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors.
Stadler JC; Keller L; Mess C; Bauer AT; Koett J; Geidel G; Heidrich I; Vidal-Y-Sy S; Andreas A; Stramaglia C; Sementsov M; Haberstroh W; Deitert B; Hoehne IL; Reschke R; Haalck T; Pantel K; Gebhardt C; Schneider SW
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37258039
[TBL] [Abstract] [Full Text] [Related]
20. Neoadjuvant Immune Checkpoint Inhibition in Metastatic Conjunctival Melanoma.
Fan K; Waninger JJ; Yentz S; McLean S; Demirci H
Ophthalmic Plast Reconstr Surg; 2023 Sep-Oct 01; 39(5):e152-e155. PubMed ID: 37207285
[TBL] [Abstract] [Full Text] [Related]
[Next]
